Radient Pharmaceuticals Corporation fka RXPC

[jimtash]

Here it is folks. Arima admitting in writing that it is looking to go public via a merger into an OTC stock.

In view of the detection of the cancer, the efficacy of cancer treatment and cancer treatment to assess the importance of cancer treatment for as much tumor drug development. Board Resolution Arima will be completed in 2015 in all internal protracted process review, 2016 to obtain an unqualified accountant submissions, 2016 public offering and listing made by Emerging, 2017 by the Emerging into OTC company.

Successful public offering and listing will give Arima certain corporate social responsibility and care for the clinical needs of the mission, despite an increase in responsibility and burden, but will also strengthen the company's constitution and lift to raise social awareness of Arima Arima more outstanding talent to join the team. Arima will be able to face greater challenges and to assume more and more large-scale research and development and the market value of new drugs, new medical technologies, new medical devices and new diagnostic techniques of.

Go to the link below and click on the vision tab.

http://translate.google.com/translate?hl=en&sl=zh-TW&u=http://www.uni-pharma.com/&prev=search